Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1388320/000121390018005849/f10q0318_actinium.htm
SEC Filings
ATNM Annual Reports
10-K Annual Report March 2022
10-K Annual Report March 2021
10-K Annual Report May 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report March 2015
10-K Annual Report February 2014
10-K Annual Report March 2013
10-K Annual Report March 2022
10-K Annual Report March 2021
10-K Annual Report May 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report March 2015
10-K Annual Report February 2014
10-K Annual Report March 2013
ATNM Quarterly Reports
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report July 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report June 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report July 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report June 2020
10-Q Quarterly Report November 2019
ATNM Corporate News
Regulated Disclosure March 2023
Financial Exhibit
Regulated Disclosure February 2023
Event for Officers
Financial Exhibit
Vote of Security Holders December 2022
Other Events December 2022
Financial Exhibit
Regulated Disclosure October 2022
Financial Exhibit
New Agreement June 2022
New Agreement April 2022
Event for Officers
Financial Exhibit
Vote of Security Holders November 2021
Event for Officers
Financial Exhibit
Regulated Disclosure September 2021
Event for Officers
Financial Exhibit
Vote of Security Holders November 2020
Regulated Disclosure
March 2023
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
February 2023
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
December 2022
Other Events
December 2022
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
October 2022
Financial Exhibit
New Agreement
New Agreement
June 2022
New Agreement
April 2022
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
November 2021
Event for Officers
Financial Exhibit
Regulated Disclosure
Financial Exhibit
Regulated Disclosure
September 2021
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
November 2020
Last10K.com | 10-Q Quarterly Report Thu May 10 2018
Document and Entity Information - shares | 3 Months Ended | |
|---|---|---|
Mar. 31, 2018 | May 10, 2018 | |
| Document and Entity Information [Abstract] | ||
| Entity Registrant Name | Actinium Pharmaceuticals, Inc. | |
| Entity Central Index Key | 0001388320 | |
| Trading Symbol | atnm | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --12-31 | |
| Document Type | 10-Q | |
| Document Period End Date | Mar. 31, 2018 | |
| Document Fiscal Year Focus | 2018 | |
| Document Fiscal Period Focus | Q1 | |
| Entity Filer Category | Accelerated Filer | |
| Entity Common Stock, Shares Outstanding | 110,317,228 |
View differences made from one quarter to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Actinium Pharmaceuticals, Inc..
Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Consolidated Balance Sheets (unaudited)
Consolidated Balance Sheets (unaudited) (parenthetical)
Consolidated Statements Of Cash Flows (unaudited)
Consolidated Statements Of Operations (unaudited)
Commitments And Contingencies
Commitments And Contingencies (details)
Description Of Business And Summary Of Significant Accounting Policies
Description Of Business And Summary Of Significant Accounting Policies (details 1)
Description Of Business And Summary Of Significant Accounting Policies (details Textual)
Description Of Business And Summary Of Significant Accounting Policies (details)
Description Of Business And Summary Of Significant Accounting Policies (policies)
Description Of Business And Summary Of Significant Accounting Policies (tables)
Equity
Equity (details Textual)
Equity (details)
Equity (tables)
Related Party Transactions
Related Party Transactions (details Textual)
Related Party Transactions (details)
Related Party Transactions (tables)
Subsequent Event
Subsequent Event (details)
Material Contracts, Statements, Certifications & more
Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ATNM
CIK: 1388320
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-18-005849
Submitted to the SEC: Thu May 10 2018 4:32:49 PM EST
Accepted by the SEC: Thu May 10 2018
Period: Saturday, March 31, 2018
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/atnm/0001213900-18-005849.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...